These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24146331)

  • 1. Imaging of a case of benign carotidynia with ultrasound, MRI and PET-CT.
    Berzaczy D; Domenig CM; Beitzke D; Bodner G
    Wien Klin Wochenschr; 2013 Nov; 125(21-22):719-20. PubMed ID: 24146331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F] Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia.
    Amaravadi RR; Behr SC; Kousoubris PD; Raja S
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1197-9. PubMed ID: 18356468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.
    Kitajima K; Ueno Y; Maeda T; Murakami K; Kaji Y; Kita M; Suzuki K; Sugimura K
    Jpn J Radiol; 2011 Nov; 29(9):605-8. PubMed ID: 21956364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
    Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
    Hjelmgren O; Johansson L; Prahl U; Schmidt C; Fredén-Lindqvist J; Bergström GML
    Eur J Radiol; 2014 Jul; 83(7):1184-1189. PubMed ID: 24767629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
    Beheshti M; Kim CK
    PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
    [No Abstract]   [Full Text] [Related]  

  • 10. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Imaging of Small and Large Bowel.
    Das CJ; Manchanda S; Panda A; Sharma A; Gupta AK
    PET Clin; 2016 Jan; 11(1):21-37. PubMed ID: 26590441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
    Cerci JJ; Tabacchi E; Bogoni M
    PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT Imaging of Carotid Atherosclerosis.
    Ali A; Tawakol A
    Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.
    Oh G; O'Mahoney E; Jeavons S; Law P; Ngai S; McGill G; Yu C; Miles KA
    J Med Imaging Radiat Oncol; 2020 Apr; 64(2):204-210. PubMed ID: 32037655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
    Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitis.
    Demirev A; Weijers R; Geurts J; Mottaghy F; Walenkamp G; Brans B
    Skeletal Radiol; 2014 May; 43(5):665-72. PubMed ID: 24609810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.